Drug Utilization of Boceprevir & Clinical Management of Health Outcomes of

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

See also
Status	Clinical Trial	Phase
Completed	`NCT02161952` - Pirfenidone, an Antifibrotic and Antiinflammatory Drug	Phase 2
Not yet recruiting	`NCT06373198` - Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.
Completed	`NCT01183169` - Efficacy and Safety of DEB025 Combined With Peg-IFN Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Relapsers and Non-responders	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT02161952 - Pirfenidone, an Antifibrotic and Antiinflammatory Drug

Phase 2

Not yet recruiting

NCT06373198 - Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.

Completed

NCT01183169 - Efficacy and Safety of DEB025 Combined With Peg-IFN Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Relapsers and Non-responders

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01544582
Study type	Observational
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	N/A
Start date	May 2012
Completion date	June 2015

Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms